Author: Signorovitch James E.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.28, Iss.10, 2010-10, pp. : 935-945
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Clinical Drug Investigation, Vol. 31, Iss. 9, 2011-09 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis: 25 case reports
Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1209, 2008-01 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis: 6 case reports
Reactions Weekly, Vol. 1, Iss. 1438, 2013-01 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis (first report with adalimumab): 5 case reports
Reactions Weekly, Vol. 1, Iss. 1075, 2005-01 ,pp. :